Neuraxis announces new medical policy coverage in North Dakota

NeurAxis announced the publication of medical policy coverage for Percutaneous Electrical Nerve Field Stimulation, effective 05/06/2024, with a Blue Cross Blue Shield licensee in North Dakota. The BCBS licensee is the largest provider of health care coverage in North Dakota, insuring and/or administering claims for over 310,000 people, effective May 6, 2024. IB-Stim is a non-surgical device that sends gentle electrical impulses into cranial nerve bundles in the ear. Neuraxis’ PENFS technology is FDA-cleared for functional abdominal pain associated with irritable bowel syndrome in adolescents 11-18 years old. There are currently no FDA-approved drug therapies for children with abdominal pain-related disorders of the gut-brain interaction. The current medical treatments, which are off-label drugs, can often have serious side effects, and most lack scientific evidence of efficacy.